CeriBell, Inc.
CBLLNASDAQHealthcare● Active
$18.14
$-0.11(-0.60%)
Market Cap$688280578
P/E Ratio—
52W High$24.33
52W Low$10.85
CeriBell, Inc.（CBLL）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CBLL · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | ($53.41M) | ($40.45M) | ($29.46M) | ($37.16M) |
| Depreciation & Amort. | ($0.67M) | $1.14M | $0.85M | $0.50M |
| Stock-Based Comp. | $12.22M | $5.41M | $2.68M | $7.93M |
| Change in Working Capital | $0.63M | ($3.17M) | ($3.70M) | ($3.88M) |
| Net Cash from Operations | ($40.81M) | ($35.04M) | ($29.16M) | ($32.00M) |
| Investing Activities | ||||
| Capital Expenditure | ($0.77M) | ($1.34M) | ($0.98M) | ($0.52M) |
| Purchases of Investments | ($210.81M) | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $94.20M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($118.14M) | ($1.60M) | ($1.76M) | ($1.40M) |
| Financing Activities | ||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $7.91M | ($3.75M) | ($0.04M) |
| Net Cash from Financing | $5.05M | $196.52M | ($2.82M) | $49.80M |
| Free Cash Flow | ||||
| Free Cash Flow | ($41.58M) | ($36.38M) | ($30.14M) | ($32.52M) |
| FCF Margin %(computed) | -46.68% | -55.59% | -66.65% | -125.45% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解CeriBell, Inc.
关于CeriBell, Inc.（CBLL）现金流量表
CeriBell, Inc. 2025财年经营活动现金流($0.04B)，自由现金流($0.04B)（FCF利润率-46.68%），资本支出($0.00B)。
常见问题
CBLL · 4 问CeriBell, Inc. 2025财年自由现金流($0.04B)，同比down14.3%。
CBLL free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10